Spectrum of tardive syndromes: clinical recognition and management
Bhidayasiri and Boonyawairoj
Postgrad. Med. J. 2011;87:132-141.
ABSTRACT
| FULL TEXT
Dyskinesia and Parkinsonism in Antipsychotic-Naive Patients With Schizophrenia, First-Degree Relatives and Healthy Controls: A Meta-analysis
Koning et al.
Schizophr Bull 2010;36:723-731.
ABSTRACT
| FULL TEXT
Neurological Signs and Involuntary Movements in Schizophrenia: Intrinsic To and Informative on Systems Pathobiology
Whitty et al.
Schizophr Bull 2009;35:415-424.
ABSTRACT
| FULL TEXT
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
Young et al.
Br. J. Psychiatry 2009;194:40-48.
ABSTRACT
| FULL TEXT
The Role of Pharmacogenetics in Treating Central Nervous System Disorders
Patnaik et al.
Exp Biol Med 2008;233:1504-1509.
ABSTRACT
| FULL TEXT
Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia
Kenney et al.
J Clin Pharmacol 2008;48:379-384.
FULL TEXT
Drug-Induced Movement Disorders
Claxton et al.
Journal of Pharmacy Practice 2007;20:415-429.
ABSTRACT
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone
TOHEN et al.
Br. J. Psychiatry 2004;184:337-345.
ABSTRACT
| FULL TEXT
A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania
Tohen et al.
Arch Gen Psychiatry 2003;60:1218-1226.
ABSTRACT
| FULL TEXT
Pharmacogenomics in schizophrenia: the quest for individualized therapy
Basile et al.
Hum Mol Genet 2002;11:2517-2530.
ABSTRACT
| FULL TEXT
Use of antipsychotic drugs and lithium in mania
COOKSON
Br. J. Psychiatry 2001;178:s148-s156.
ABSTRACT
| FULL TEXT
Incidence and Correlates of Tardive Dyskinesia in First Episode of Schizophrenia
Chakos et al.
Arch Gen Psychiatry 1996;53:313-319.
ABSTRACT
Duration of Neuroleptic Treatment and Prevalence of Tardive Dyskinesia in Late Life
Sweet et al.
Arch Gen Psychiatry 1995;52:478-486.
ABSTRACT
Risk Factors for Spontaneous Dyskinesia in Schizophrenia
Fenton et al.
Arch Gen Psychiatry 1994;51:643-650.
ABSTRACT
Fluoxetine Induced Dyskinesia
Mander et al.
Aust N Z J Psychiatry 1994;28:328-330.
ABSTRACT
Identifying Risk Factors for Tardive Dyskinesia Among Long-term Outpatients Maintained With Neuroleptic Medications: Results of the Yale Tardive Dyskinesia Study
Morgenstern and Glazer
Arch Gen Psychiatry 1993;50:723-733.
ABSTRACT
The First Lithium Clinic in Hong Kong: A Chinese Profile
Lee
Aust N Z J Psychiatry 1992;26:450-453.
ABSTRACT
Dyskinesia and Neuroleptic Exposure in Elderly Psychiatric Inpatients
Sweet et al.
J Geriatr Psychiatry Neurol 1992;5:156-161.
ABSTRACT
Prospective Study of Tardive Dyskinesia Incidence in the Elderly
Saltz et al.
JAMA 1991;266:2402-2406.
ABSTRACT
Tardive Dyskinesia in Alzheimer's Disease: Clinical Features and Neuropathologic Correlates
McDaniel et al.
J Geriatr Psychiatry Neurol 1991;4:79-85.
ABSTRACT
Tardive Dyskinesia in Elderly Psychiatric Patients in Singapore
Tan and Tay
Aust N Z J Psychiatry 1991;25:119-122.
ABSTRACT
The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics: A Controlled Study
Ganzini et al.
Arch Gen Psychiatry 1991;48:259-263.
ABSTRACT
Is Spontaneous Orofacial Dyskinesia an Artefact Due to Incomplete Drug History?
Ticehurst
J Geriatr Psychiatry Neurol 1990;3:208-211.
ABSTRACT
ECT and Tardive Dyskinesia
Hay et al.
J Geriatr Psychiatry Neurol 1990;3:106-109.
ABSTRACT
Tardive Dystonia
Chiu and Lee
Aust N Z J Psychiatry 1989;23:566-570.
ABSTRACT
Metoclopramide-Induced Movement Disorders: Clinical Findings With a Review of the Literature
Miller and Jankovic
Arch Intern Med 1989;149:2486-2492.
ABSTRACT
Tardive Dyskinesia in Italy: Preliminary Findings
Muscettola et al.
Arch Gen Psychiatry 1989;46:754-755.
ABSTRACT
Significance of Neuroleptic Dose and Plasma Level in the Pharmacological Treatment of Psychoses
Baldessarini et al.
Arch Gen Psychiatry 1988;45:79-91.
ABSTRACT
Cognitive Dysfunction, Negative Symptoms, and Tardive Dyskinesia in Schizophrenia: Their Association in Relation to Topography of Involuntary Movements and Criterion of Their Abnormality
Waddington et al.
Arch Gen Psychiatry 1987;44:907-912.
ABSTRACT
Tardive Dyskinesia and Steady-State Serum Levels of Thiothixene
Yesavage et al.
Arch Gen Psychiatry 1987;44:913-915.
ABSTRACT
Brain {gamma}-Aminobutyric Acid Abnormality in Tardive Dyskinesia: Reduction in Cerebrospinal Fluid GABA Levels and Therapeutic Response to GABA Agonist Treatment
Thaker et al.
Arch Gen Psychiatry 1987;44:522-529.
ABSTRACT
Review Article: Psychopharmacologic Treatment in Neurological Practice
Dubovsky and Ringel
Neurorehabil Neural Repair 1987;1:51-66.
Tardive Dyskinesia in Young Mentally Retarded Individuals
Gualtieri et al.
Arch Gen Psychiatry 1986;43:335-340.
ABSTRACT
Penrsistent Tardive Dyskinesia in Bipolar Patients
Mukherjee et al.
Arch Gen Psychiatry 1986;43:342-346.
ABSTRACT
Duration of Treatment Relationships for Involuntary Movements (Tardive Dyskinesia): Concordance Between Cross-sectional, Clinical, and Longitudinal Animal Studies?
Waddington and Molloy
Arch Gen Psychiatry 1986;43:191-191.
ABSTRACT
Schizophrenics With Tardive Dyskinesia: Neuropsychological Deficit and Family Psychopathology
Wegner et al.
Arch Gen Psychiatry 1985;42:860-865.
ABSTRACT
Tardive Dyskinesia in the Aged: Duration of Treatment Relationships
Toenniessen et al.
Arch Gen Psychiatry 1985;42:278-284.
ABSTRACT
Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics: I. Preliminary Results for Relapse Rates
Kane et al.
Arch Gen Psychiatry 1983;40:893-896.
ABSTRACT
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment
Waddington et al.
Science 1983;220:530-532.
ABSTRACT
Clozapine and Tardive Dyskinesia
Singer
Arch Gen Psychiatry 1983;40:347-347.
ABSTRACT
